Target intelligence / Profile preview

Kelch-like family member 40 (KLHL40)

Target
KLHL40
Molecular classification
Other (Kelch-like family member), Substrate-specific adapter for BTB-CUL3-RBX1 E3 ubiquitin ligase complex, Actin-binding-related protein (via Kelch domains)
01

Overview

Kelch-like family member 40 (KLHL40) is a protein characterized by the presence of BTB/POZ, BACK, and Kelch repeat domains[1][3]. It primarily acts as a substrate-specific adapter for the BTB-CUL3-RBX1 E3 ubiquitin ligase complex and is a key regulator of skeletal muscle development[1][2]. KLHL40 promotes stabilization of muscle thin filament proteins nebulin (NEB) and leiomodin-3 (LMOD3), inhibiting their ubiquitination and preventing their proteasome-mediated degradation[2]. Unlike most BTB-Kelch proteins that drive substrate degradation, KLHL40 uniquely maintains thin filament protein levels, ensuring proper sarcomere structure and function[2]. Mutations in KLHL40 reduce NEB and LMOD3 abundance, causing sarcomere disruption and resulting in a severe form of nemaline myopathy characterized by profound muscle weakness and early lethality[1][2]. The gene is evolutionarily conserved and its dysfunction represents a rare but well-established cause of congenital myopathy. Currently, KLHL40 is not a drug target, but its molecular role makes it of interest for understanding muscle maintenance and related diseases[3].

Other names
Kelch-like protein 40KBTBD5Sarcosynapsinkelch repeat and BTB domain-containing protein 5nemaline myopathy type 8SRYPSYRPNEM8
02

Mechanism of action

no drugs, hence no mechanisms, but hypothetically, modulation could involve altering ubiquitination or stabilization of sarcomere proteins

03

Biological functions

Skeletal muscle developmentRegulation of thin filament stability in muscle fibersNegative regulation of ubiquitination and proteasome-mediated degradation for key thin filament proteins (NEB, LMOD3)
04

Disease associations

Nemaline myopathy type 8 (severe congenital nemaline myopathy)Other muscle disorders (potential/related via pathways)
05

Safety considerations

Loss-of-function is associated with severe congenital muscle weakness, respiratory failure, and early lethality in nemaline myopathyTherapeutic targeting may risk muscle function deterioration if not precise
06

Biomarkers

Mutational analysis of KLHL40 for congenital myopathy diagnosis

Beyond the preview

Go deeper on Kelch-like family member 40 (KLHL40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like family member 40 (KLHL40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call